ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tabrecta 200 mg, Filmtabletten - 120
67648002 Novartis Pharma Schweiz AG
Tabrecta 200 mg, Filmtabletten26.04.2021
  26.04.2021
Capmatinib (L01EX17) 
WHO-DDD06.03.2028
07.16.10.120
07.16.10. 
A  
Yes 
IP 
5503.34Yes
    
10 %5954.25
  
7680676480028Synthetika
  
Composition
capmatinibum 200 mg ut capmatinibi hydrochloridum monohydricum, cellulosum microcristallinum, mannitolum, crospovidonum, povidonum K 30, magnesii stearas, silica colloidalis anhydrica, natrii laurilsulfas corresp. natrium 0.16 mg, Überzug: hypromellosum, E 171, macrogolum 4000, talcum, E 172 (flavum), pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Capmatinibum200 mg
BAG: Active AgentDose
Capmatinibum200 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
Cellulosum Microcristallinum  
Crospovidonum  
E 171 color.
E 172 color.
Hypromellosum Überzug
Macrogol4000  
Magnesii Stearas  
Mannitol  
Natrii Laurilsulfas  
Povidonum K30  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 03.03.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home